Heteroaryl substituted pyridines and methods of use
US10138227B2 · kind B2 · utility
29Cited by
5References
29Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 23, 2017 |
| Grant date | Nov 27, 2018 |
| Priority date | — |
| Expiry date | May 23, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention discloses compounds of Formula I, wherein X1, X2, R1, and R2 are as defined herein. The present invention relates to compounds and their use in the treatment of cystic fibrosis, methods for their production, pharmaceutical compositions comprising the same, and methods of treating cystic fibrosis by administering a compound of the invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.